Archive - May 2022
Gilead signs $300m deal with Dragonfly to advance immunotherapies
New NHS prenatal test for rare form of eye cancer
STORM Therapeutics receives Innovate UK grant
STORM Therapeutics receives Innovate UK grant
Byondis and Medac link up to commercialise trastuzumab duocarmazine
Idorsia’s Quviviq approved for adults with chronic insomnia disorder
Understanding the FDA’s transition plan for drugs with EUAs
Another COVID-19 Surge In US Expected By Summer, Birx Says